60
Participants
Start Date
May 17, 2023
Primary Completion Date
January 1, 2027
Study Completion Date
January 1, 2028
PM8002
IV infusion
FOLFIRI
IV infusion
RECRUITING
Chongqing University Cancer Hospital, Chongqing
RECRUITING
Fujian Province Cancer Hospital, Fuzhou
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
RECRUITING
Jingzhou First People's Hospital, Jingzhou
RECRUITING
Union Hospital Tongji Medical College of Hust, Wuhan
RECRUITING
Hunan Cancer Hospital, Changsha
RECRUITING
The Central Hospital of Yongzhou, Yongzhou
RECRUITING
Nanjing Drum Tower Hospital, Nanjing
RECRUITING
Shandong Cancer Hospital, Jinan
RECRUITING
Yunnan Cancer Hospital (The Third Affiliated Hospital of Kunming Medical University), Kunming
RECRUITING
Chinese PLA General Hospital, Beijing
RECRUITING
ZhongShan Hospital Fudan University, Shanghai
Lead Sponsor
Biotheus Inc.
INDUSTRY